FindTrial
Sign In

Adjuvant treatment of Pseudomonas Aeruginosa Injection in patients with hepatocellular carcinoma after curative surgery

Adjuvant treatment of Pseudomonas Aeruginosa Injection in patients with hepatocellular carcinoma after curatiive surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-11001241
Enrollment
Unknown
Registered
2011-03-24
Start date
2011-04-10
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular carcinoma

Interventions

test:wtih treatment of Pseudomonas Aeruginosa Injection after surgery
control:without adjuvant treatment after surgery

Sponsors

Eastern Hepatobiliary Surgery Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Complete resection of the tumor; 2. Tumor exposed or with satellites; 3. Microvascular invasion in postoperative pathology

Exclusion criteria

Exclusion criteria: 1. Allergy to penicillin or pseudomonas aeruginosa; 2. Deaths during hospitalization; 3. Use of other immune agents

Design outcomes

Primary

MeasureTime frame
1-,3-,5-year recurrence free survival;—

Secondary

MeasureTime frame
1-,3-,5-year overall survival and safety;—

Countries

China

Contacts

Public ContactYiqun YAN
ehbhyyq@163.com+86 21 81875501

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026